Zacks Investment Research·Sep 4, 2026
Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
Perrigo's fundamental outlook is clouded by persistent revenue contraction and margin erosion, with gross margin down 690 bps to 30.7% in 2026Q2 and revenue declining for eight consecutive quarters. However, the company's cash generation has shown resilience, ...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.50+28.9% vs $0.39 | $1.0B+0.7% vs $1.0B |
Q2 2026 May 6, 2026 | $0.43+10.3% vs $0.39 | $969M-6.4% vs $1.0B |
Q1 2026 Feb 26, 2026 | $0.77-3.8% vs $0.80 | $1.1B+0.7% vs $1.1B |
Q4 2025 Nov 5, 2025 | $0.80+6.7% vs $0.75 | $1.0B-4.5% vs $1.1B |
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Barclays Global Consumer Conference on Thursday, September 10th, 2026. About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe.
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Benchmark PRGO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Perrigo Company plc (PRGO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $13.84 | $1.92B | -1.35 | -2.75% | -33.51% | -39.29% | 8.31% | |
| $9.11 | $40.63B | 19.11 | -1.81% | 14.18% | 19.35% | — | |
| $0.73 | $82.04M | -0.76 | -38.97% | -19.96% | -41.94% | — | |
| $45.92 | $2.18B | 11.74 | -4.31% | 15.57% | 9.22% | — | |
| $3.50 | $134.55M | -2.89 | -5.25% | -12.42% | -15.46% | — | |
| $39.01 | $46.07B | 32.51 | 4.31% | 4.08% | 9.06% | — |
Perrigo Company plc (PRGO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Perrigo Company plc (PRGO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jul 6, 2026·SEC
Jun 30, 2026·SEC
Get notified when PRGO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Perrigo Company plc (PRGO) stock FAQ — growth, dividends, profitability & financials explained
Perrigo Company plc (PRGO) reported $4.14B in revenue for fiscal year 2025. This represents a 433% increase from $778.1M in 1996.
Perrigo Company plc (PRGO) saw revenue decline by 2.8% over the past year.
Perrigo Company plc (PRGO) reported a net loss of $1.73B for fiscal year 2025.
Yes, Perrigo Company plc (PRGO) pays a dividend with a yield of 8.31%. This makes it attractive for income-focused investors.
Perrigo Company plc (PRGO) has a return on equity (ROE) of -39.3%. Negative ROE indicates the company is unprofitable.
Perrigo Company plc (PRGO) generated $175.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
